Form 4: Vivani Medical Director Receives Stock Options

Vivani Medical, Inc. reports that Director Alexandra L. Popoff was granted stock options as part of her annual compensation.

Summary

• Alexandra L. Popoff, a Director at Vivani Medical, Inc., received a grant of 36,516 non-qualified stock options on June 24, 2026.
• The stock options have an exercise price of $1.22 per share.
• These options are part of an annual grant under the company's Non-Employee Director Compensation Policy.
• The options vest on the earlier of the first anniversary of the grant date or the next annual stockholder meeting, contingent upon continued service.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a standard director compensation event rather than a significant financial or strategic development for the company.

Positives

• Director compensation includes equity incentives, aligning director interests with shareholders.
• The grant is part of a structured compensation policy for non-employee directors.

Risks

• The value of the stock options is directly tied to the future performance and stock price of Vivani Medical, Inc.
• Continued service is a condition for vesting, meaning a director's departure before vesting would result in forfeiture of the options.

Future Outlook

The future outlook for the stock options depends on the company's performance and stock price appreciation, as they vest over time and have an expiration date.

Industry Context

StockSavvy.ai notes that granting stock options to directors is a common practice in the biotechnology and medical technology sectors to attract and retain experienced leadership and align their financial interests with those of shareholders.

Corporate Governance

Related Party Transactions

• The grant of stock options to Director Alexandra L. Popoff is a related party transaction, as it involves compensation to a company insider.

Stakeholder Impact

• Shareholders: The grant aligns director incentives with shareholder interests, potentially leading to decisions that enhance stock value. Dilution may occur if options are exercised.
• Directors: Provides potential financial upside tied to company performance.
• Employees: The focus on director compensation does not directly impact employees in this filing.

Next Steps

• Continued service by Alexandra L. Popoff through the vesting dates.
• Potential exercise of stock options if the stock price exceeds the exercise price of $1.22.
• Monitoring of Vivani Medical, Inc.'s performance and stock price.

Key Dates

Keywords

Vivani Medical, VANI, Form 4, Stock Options, Director Compensation, SEC Filing, Equity Grant, Beneficial Ownership